These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31669585)

  • 1. Characterization of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidases from Borrelia burgdorferi: Antibiotic targets for Lyme disease.
    Cornell KA; Knippel RJ; Cortright GR; Fonken M; Guerrero C; Hall AR; Mitchell KA; Thurston JH; Erstad P; Tao A; Xu D; Parveen N
    Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129455. PubMed ID: 31669585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of methylthioadenosine/S-adenosylhomocysteine nucleosidases of Borrelia burgdorferi as targets for novel antimicrobials using a novel high-throughput method.
    Cornell KA; Primus S; Martinez JA; Parveen N
    J Antimicrob Chemother; 2009 Jun; 63(6):1163-72. PubMed ID: 19376840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of substrate specificity in 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidases.
    Siu KK; Asmus K; Zhang AN; Horvatin C; Li S; Liu T; Moffatt B; Woods VL; Howell PL
    J Struct Biol; 2011 Jan; 173(1):86-98. PubMed ID: 20554051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate preference of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase in Burkholderia thailandensis.
    Gao Q; Zheng D; Yuan Z
    FEMS Microbiol Lett; 2013 Feb; 339(2):110-6. PubMed ID: 23198993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Nucleoside Analogs as Antimicrobials Targeting Unique Enzymes in
    Chakraborti M; Schlachter S; Primus S; Wagner J; Sweet B; Carr Z; Cornell KA; Parveen N
    Pathogens; 2020 Aug; 9(9):. PubMed ID: 32825529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes.
    Mosel MR; Carolan HE; Rebman AW; Castro S; Massire C; Ecker DJ; Soloski MJ; Aucott JN; Eshoo MW
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036693
    [No Abstract]   [Full Text] [Related]  

  • 7. Femtomolar transition state analogue inhibitors of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase from Escherichia coli.
    Singh V; Evans GB; Lenz DH; Mason JM; Clinch K; Mee S; Painter GF; Tyler PC; Furneaux RH; Lee JE; Howell PL; Schramm VL
    J Biol Chem; 2005 May; 280(18):18265-73. PubMed ID: 15749708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent Proteins, Promoters, and Selectable Markers for Applications in the Lyme Disease Spirochete Borrelia burgdorferi.
    Takacs CN; Kloos ZA; Scott M; Rosa PA; Jacobs-Wagner C
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30315081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.
    Pothineni VR; Potula HSK; Ambati A; Mallajosyula VVA; Sridharan B; Inayathullah M; Ahmed MS; Rajadas J
    Sci Rep; 2020 Mar; 10(1):3798. PubMed ID: 32123189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.
    Johnson RC; Kodner CB; Jurkovich PJ; Collins JJ
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2133-6. PubMed ID: 2073103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening.
    Pothineni VR; Wagh D; Babar MM; Inayathullah M; Solow-Cordero D; Kim KM; Samineni AV; Parekh MB; Tayebi L; Rajadas J
    Drug Des Devel Ther; 2016; 10():1307-22. PubMed ID: 27103785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.
    Feng J; Shi W; Zhang S; Zhang Y
    Emerg Microbes Infect; 2015 Jun; 4(6):e31. PubMed ID: 26954881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.
    Sharma B; Brown AV; Matluck NE; Hu LT; Lewis K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4616-24. PubMed ID: 26014929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of Staphylococcus aureus 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase.
    Siu KK; Lee JE; Smith GD; Horvatin-Mrakovcic C; Howell PL
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 May; 64(Pt 5):343-50. PubMed ID: 18453700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.
    Caol S; Divers T; Crisman M; Chang YF
    BMC Vet Res; 2017 Sep; 13(1):293. PubMed ID: 28962614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-Related Differential Stimulation of Immune Response by
    Djokic V; Primus S; Akoolo L; Chakraborti M; Parveen N
    Front Immunol; 2018; 9():2891. PubMed ID: 30619263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi.
    Wu X; Sharma B; Niles S; O'Connor K; Schilling R; Matluck N; D'Onofrio A; Hu LT; Lewis K
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126963
    [No Abstract]   [Full Text] [Related]  

  • 18. A selective antibiotic for Lyme disease.
    Leimer N; Wu X; Imai Y; Morrissette M; Pitt N; Favre-Godal Q; Iinishi A; Jain S; Caboni M; Leus IV; Bonifay V; Niles S; Bargabos R; Ghiglieri M; Corsetti R; Krumpoch M; Fox G; Son S; Klepacki D; Polikanov YS; Freliech CA; McCarthy JE; Edmondson DG; Norris SJ; D'Onofrio A; Hu LT; Zgurskaya HI; Lewis K
    Cell; 2021 Oct; 184(21):5405-5418.e16. PubMed ID: 34619078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.
    Preac-Mursic V; Weber K; Pfister HW; Wilske B; Gross B; Baumann A; Prokop J
    Infection; 1989; 17(6):355-9. PubMed ID: 2613324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health impact of strain specific immunity to Borrelia burgdorferi.
    Khatchikian CE; Nadelman RB; Nowakowski J; Schwartz I; Levy MZ; Brisson D; Wormser GP
    BMC Infect Dis; 2015 Oct; 15():472. PubMed ID: 26503011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.